These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16552811)

  • 21. [A case of paclitaxel-resistant cancerous ascites secondary to gastric carcinoma responding well to TS-1 therapy].
    Hara A; Tsunemi S; Yamamoto M; Izumi N; Iwamoto S
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2065-7. PubMed ID: 17197755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of intraperitoneal paclitaxel administration in a gastric cancer patient with severely impaired renal function].
    Ohbu M; Maruyama M; Miyawaki Y; Tamura N; Koide A; Hasegawa K; Maruyama S; Takashima I; Ebuchi M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1745-7. PubMed ID: 16315928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma.
    Kodera Y; Ito Y; Ito S; Ohashi N; Mochizuki Y; Yamamura Y; Koike M; Fujiwara M; Nakanishi H; Nakao A
    Hepatogastroenterology; 2007; 54(75):960-3. PubMed ID: 17591103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of neutrophil reduction using plasma paclitaxel concentration after administration in patients with uterine, ovarian, or cervical cancers in an outpatient clinic.
    Ishikawa M; Kawai M; Maeda T; Kagawa Y
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):399-411. PubMed ID: 29299638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous administration of paclitaxel in Sprague-Dawley rats: what is a safe dose?
    Shord SS; Camp JR
    Biopharm Drug Dispos; 2006 May; 27(4):191-6. PubMed ID: 16566060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of paclitaxel in a hemodialysis patient with advanced gastric cancer: A case report.
    Kawate S; Takeyoshi I; Morishita Y
    World J Gastroenterol; 2006 Aug; 12(32):5237-9. PubMed ID: 16937541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel].
    Ueno S; Nakakuma T; Aramaki N; Shiozawa K; Iizuka M; Kurita A; Miyauchi K; Sengoku N; Kuranami M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2471-3. PubMed ID: 20037459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case report of advanced gastric cancer with carcinomatous ascites successfully treated by outpatient chemotherapy].
    Ohtani S; Shimizu Y; Sugiyama S; Miyade Y; Ninomiya M
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):85-7. PubMed ID: 17220677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weekly paclitaxel as second-line chemotherapy in Japanese patients with advanced gastric cancer.
    Kadokura M; Iwasa S; Honma Y; Kato K; Hamaguchi T; Yamada Y; Enomoto N; Shimada Y
    Anticancer Res; 2013 Oct; 33(10):4547-52. PubMed ID: 24123029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful Long-term Management with a Single Administration of Tri-weekly Nab-paclitaxel in a Patient with Advanced Gastric Cancer with Peritoneal Dissemination.
    Matano D; Moriwaki T; Tange Y; Niisato Y; Yamaura M; Nagase M; Suganuma D; Takagi Taketa K; Iwai K; Enami C; Yamamoto Y; Hyodo I
    Intern Med; 2017; 56(8):921-923. PubMed ID: 28420840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination].
    Fushida S; Nao F; Kinami S; Ninomiya I; Fujimura T; Nishimura G; Ohta T; Yokogawa K; Miyamoto K; Miwa K
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1759-63. PubMed ID: 12402426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of advanced gastric cancer with carcinomatosa peritonitis effectively treated by 5-FU and low-dose CDDP therapy].
    Saito E; Kunii Y; Wada G; Tsuchiya S; Yamasaki T; Sakakibara N
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1153-6. PubMed ID: 9239170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1].
    Shibata N; Eto TA; Hotokezaka M; Iwamura T; Chijiiwa K
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1159-62. PubMed ID: 16121920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case responding to weekly paclitaxel (TXL) therapy as third line chemotherapy for scirrhous type gastric cancer].
    Sagawa T; Tsuji Y; Takayanagi N; Hirayama Y; Sakamaki S; Chiba H; Nakajima T; Iyama S; Oku T; Sumiyoshi T; Sato Y; Takahashi M; Takayama T; Niitsu Y
    Gan To Kagaku Ryoho; 2003 May; 30(5):707-10. PubMed ID: 12795107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics of paclitaxel liposome with a new route of administration in human based on the analysis with ultra performance liquid chromatography.
    Wang X; Zheng H; Zhu Z; Wei Y; Chen L
    J Pharm Sci; 2010 Nov; 99(11):4746-52. PubMed ID: 20845471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.
    Bulitta JB; Zhao P; Arnold RD; Kessler DR; Daifuku R; Pratt J; Luciano G; Hanauske AR; Gelderblom H; Awada A; Jusko WJ
    Cancer Chemother Pharmacol; 2009 May; 63(6):1049-63. PubMed ID: 18791718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration.
    Soma D; Kitayama J; Ishigami H; Kaisaki S; Nagawa H
    J Surg Res; 2009 Jul; 155(1):142-6. PubMed ID: 19328496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Case of advanced gastric cancer successfully treated with chemotherapy of weekly paclitaxel].
    Fujii K; Uno H; Kayo S; Ueda Y; Kawamura C; Mizuyama Y; Kaneda K; Nakagawa H; Arakawa T
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1107-9. PubMed ID: 17637550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer.
    Hironaka S; Zenda S; Boku N; Fukutomi A; Yoshino T; Onozawa Y
    Gastric Cancer; 2006; 9(1):14-8. PubMed ID: 16557431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.